Cargando…

Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves’ Ophthalmopathy

PURPOSE: The aim of this study was to investigate conjunctival goblet cell density (GCD) and tear mucin-5AC (MUC5AC) protein levels in patients with Graves’ ophthalmopathy (GO) and their association with dry eye indicators. METHODS: A total of 99 patients with GO (54 active, 45 inactive) and 40 heal...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Yayan, Chen, Jin, Chen, Hua, Wang, Jiasong, Xie, Huatao, Pi, Xiaohuan, Wang, Xinghua, Jiang, Fagang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617636/
https://www.ncbi.nlm.nih.gov/pubmed/37889503
http://dx.doi.org/10.1167/tvst.12.10.19
_version_ 1785129620615462912
author You, Yayan
Chen, Jin
Chen, Hua
Wang, Jiasong
Xie, Huatao
Pi, Xiaohuan
Wang, Xinghua
Jiang, Fagang
author_facet You, Yayan
Chen, Jin
Chen, Hua
Wang, Jiasong
Xie, Huatao
Pi, Xiaohuan
Wang, Xinghua
Jiang, Fagang
author_sort You, Yayan
collection PubMed
description PURPOSE: The aim of this study was to investigate conjunctival goblet cell density (GCD) and tear mucin-5AC (MUC5AC) protein levels in patients with Graves’ ophthalmopathy (GO) and their association with dry eye indicators. METHODS: A total of 99 patients with GO (54 active, 45 inactive) and 40 healthy controls were recruited. Comprehensive ophthalmic examinations, including the external eye, ocular surface, GCD, and tear MUC5AC ELISA, were performed. The GCD examination was performed in temporal bulbar conjunctiva, including IVCM GCD by in vivo confocal microscopy (IVCM) and filled GCD of cytokeratin-7 and MUC5AC-positive co-immunomarkers by impression cytology. Tear MUC5AC protein was detected using samples extracted from Schirmer strips. RESULTS: The GO group showed a significant decrease in IVCM GCD, filled GCD, and normalized tear MUC5AC protein compared to controls, with the active GO group showing the greatest decrease (all P < 0.05). Tear MUC5AC protein levels in GO correlated with those of IVCM GCD (r = 0.40, P < 0.001) and filled GCD (r = 0.54, P < 0.001, respectively). Higher ocular surface disease index (r = −0.22, P < 0.05; r = −0.20, P < 0.05; r = −0.21, P < 0.05) and lisamine green staining (r = −0.23, P < 0.05; r = −0.38, P < 0.001; r = −0.42, P < 0.001) were associated with lower tear MUC5AC protein levels, IVCM GCD, and filled GCD, respectively, which decreased with increasing clinical activity score (r = −0.24, P < 0.05; r = −0.28, P < 0.01; r = −0.27, P < 0.01) and conjunctival congestion score (r = −0.27, P < 0.01; r = −0.33, P < 0.001; r = −0.42, P < 0.001). CONCLUSIONS: The goblet cell count and tear MUC5AC protein in GO eyes were decreased, possibly due to ocular surface inflammation. TRANSLATIONAL RELEVANCE: This study observed the change of tear film mucin in GO patients.
format Online
Article
Text
id pubmed-10617636
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-106176362023-11-01 Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves’ Ophthalmopathy You, Yayan Chen, Jin Chen, Hua Wang, Jiasong Xie, Huatao Pi, Xiaohuan Wang, Xinghua Jiang, Fagang Transl Vis Sci Technol Cornea & External Disease PURPOSE: The aim of this study was to investigate conjunctival goblet cell density (GCD) and tear mucin-5AC (MUC5AC) protein levels in patients with Graves’ ophthalmopathy (GO) and their association with dry eye indicators. METHODS: A total of 99 patients with GO (54 active, 45 inactive) and 40 healthy controls were recruited. Comprehensive ophthalmic examinations, including the external eye, ocular surface, GCD, and tear MUC5AC ELISA, were performed. The GCD examination was performed in temporal bulbar conjunctiva, including IVCM GCD by in vivo confocal microscopy (IVCM) and filled GCD of cytokeratin-7 and MUC5AC-positive co-immunomarkers by impression cytology. Tear MUC5AC protein was detected using samples extracted from Schirmer strips. RESULTS: The GO group showed a significant decrease in IVCM GCD, filled GCD, and normalized tear MUC5AC protein compared to controls, with the active GO group showing the greatest decrease (all P < 0.05). Tear MUC5AC protein levels in GO correlated with those of IVCM GCD (r = 0.40, P < 0.001) and filled GCD (r = 0.54, P < 0.001, respectively). Higher ocular surface disease index (r = −0.22, P < 0.05; r = −0.20, P < 0.05; r = −0.21, P < 0.05) and lisamine green staining (r = −0.23, P < 0.05; r = −0.38, P < 0.001; r = −0.42, P < 0.001) were associated with lower tear MUC5AC protein levels, IVCM GCD, and filled GCD, respectively, which decreased with increasing clinical activity score (r = −0.24, P < 0.05; r = −0.28, P < 0.01; r = −0.27, P < 0.01) and conjunctival congestion score (r = −0.27, P < 0.01; r = −0.33, P < 0.001; r = −0.42, P < 0.001). CONCLUSIONS: The goblet cell count and tear MUC5AC protein in GO eyes were decreased, possibly due to ocular surface inflammation. TRANSLATIONAL RELEVANCE: This study observed the change of tear film mucin in GO patients. The Association for Research in Vision and Ophthalmology 2023-10-27 /pmc/articles/PMC10617636/ /pubmed/37889503 http://dx.doi.org/10.1167/tvst.12.10.19 Text en Copyright 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Cornea & External Disease
You, Yayan
Chen, Jin
Chen, Hua
Wang, Jiasong
Xie, Huatao
Pi, Xiaohuan
Wang, Xinghua
Jiang, Fagang
Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves’ Ophthalmopathy
title Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves’ Ophthalmopathy
title_full Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves’ Ophthalmopathy
title_fullStr Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves’ Ophthalmopathy
title_full_unstemmed Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves’ Ophthalmopathy
title_short Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves’ Ophthalmopathy
title_sort investigation of conjunctival goblet cell and tear muc5ac protein in patients with graves’ ophthalmopathy
topic Cornea & External Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617636/
https://www.ncbi.nlm.nih.gov/pubmed/37889503
http://dx.doi.org/10.1167/tvst.12.10.19
work_keys_str_mv AT youyayan investigationofconjunctivalgobletcellandtearmuc5acproteininpatientswithgravesophthalmopathy
AT chenjin investigationofconjunctivalgobletcellandtearmuc5acproteininpatientswithgravesophthalmopathy
AT chenhua investigationofconjunctivalgobletcellandtearmuc5acproteininpatientswithgravesophthalmopathy
AT wangjiasong investigationofconjunctivalgobletcellandtearmuc5acproteininpatientswithgravesophthalmopathy
AT xiehuatao investigationofconjunctivalgobletcellandtearmuc5acproteininpatientswithgravesophthalmopathy
AT pixiaohuan investigationofconjunctivalgobletcellandtearmuc5acproteininpatientswithgravesophthalmopathy
AT wangxinghua investigationofconjunctivalgobletcellandtearmuc5acproteininpatientswithgravesophthalmopathy
AT jiangfagang investigationofconjunctivalgobletcellandtearmuc5acproteininpatientswithgravesophthalmopathy